A carregar...

Preclinical study of a novel therapeutic vaccine for recurrent respiratory papillomatosis

Activation of antigen-specific T-lymphocyte responses may be needed to cure disorders caused by chronic infection with low-risk human papillomavirus (lrHPV). Safe and effective adjuvant therapies for such disorders are needed. The safety and efficacy of a novel gorilla adenovirus vaccine expressing...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:NPJ Vaccines
Main Authors: Lee, Maxwell Y., Metenou, Simon, Brough, Douglas E., Sabzevari, Helen, Bai, Ke, Jochems, Caroline, Schlom, Jeffrey, Allen, Clint T.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8213691/
https://ncbi.nlm.nih.gov/pubmed/34145272
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-021-00348-x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!